Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.6225 USD | -0.83% | -2.58% | -53.89% |
Business Summary
Number of employees: 58
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Molecular Testing Products
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | -98.69% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | -98.69% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Adi Mohanty
CEO | Chief Executive Officer | 57 | 07/11/21 |
Eric d'Esparbes
DFI | Director of Finance/CFO | 56 | 30/04/19 |
Ariella Kelman
CTO | Chief Tech/Sci/R&D Officer | - | 30/04/23 |
Paul W. Shabram
CTO | Chief Tech/Sci/R&D Officer | - | 24/04/22 |
Sharat Singh
CTO | Chief Tech/Sci/R&D Officer | - | - |
Michael Rhode
PRN | Corporate Officer/Principal | - | - |
Allison Luo
PRN | Corporate Officer/Principal | 50 | 31/05/17 |
Robyn Hatton
HRO | Human Resources Officer | - | 31/07/13 |
Clarke Neumann
LAW | General Counsel | 60 | 31/08/14 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 49 | 31/05/14 | |
Jeffrey Alter
CHM | Chairman | 61 | 31/12/18 |
Adi Mohanty
CEO | Chief Executive Officer | 57 | 07/11/21 |
Lynne Powell
BRD | Director/Board Member | 57 | 31/01/19 |
Brian Kotzin
BRD | Director/Board Member | 74 | 31/05/19 |
Jill Howe
BRD | Director/Board Member | 48 | 02/11/21 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 33,292,111 | 35,588,352 ( 106.90 %) | 0 | 106.90 % |
Company contact information
Biora Therapeutics, Inc.
4330 La Jolla Village Drive Suite 300
92122, San Diego
+833 727 2841
http://www.progenity.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-53.89% | 22.52M | |
-2.63% | 103B | |
+1.62% | 95.28B | |
+1.46% | 22.15B | |
-16.67% | 21.02B | |
-8.58% | 18.15B | |
-38.74% | 16.73B | |
-13.21% | 16.05B | |
+5.41% | 13.68B | |
+33.57% | 12.17B |
- Stock Market
- Equities
- BIOR Stock
- Company Biora Therapeutics, Inc.